Enterol is a leading probiotic medication widely recognized in Poland for its diverse applications in both children and adults. Its primary ingredient, Saccharomyces boulardii CNCM I-745, has been clinically validated since 1961, making it a trusted choice for treating various types of diarrhea. Enterol is specifically formulated to combat infectious diarrhea, prevent antibiotic-associated diarrhea, and manage recurring cases linked to Clostridium difficile infection.

In addition to its therapeutic uses, Enterol effectively safeguards the gastrointestinal tract during antibiotic treatments, allowing for simultaneous administration without refrigeration. This versatility extends to preventing travel-related diarrhea and supporting those with irritable bowel syndrome (IBS). Available in multiple forms, such as capsules and sachets, Enterol is not just a supplement but a rigorously tested medication that ensures safety and efficacy for all ages. Backed by over 100 clinical studies, Enterol is sold in over 90 countries, demonstrating its global acceptance and reliability among healthcare professionals and patients alike.